This inventor holds 2 USPTO granted patents. Top assignees: Veb Arzneimittelwerk Dresden, Veb Fahlberg-List Chemische Und Pharmazeutische Fabriken. Active years: 1987-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Berlin, DE (1987)
- Schwanebeck, DE (1992)
Company Filing History:
1 out of 10 
1 out of 1 Years Active: 1987-1992
Title: Jurgen Slapke: Innovator in Pharmaceutical Preparations
Introduction
Jurgen Slapke is a notable inventor based in Schwanebeck, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the bioavailability of active ingredients in drug formulations. With a total of 2 patents, his work has implications for improving drug efficacy and patient outcomes.
Latest Patents
Slapke's latest patents focus on innovative compositions and methods for providing optimum bioavailability of pharmaceutical preparations. One of his key inventions involves the active ingredient 2-hydroxy-5-methyllaurophenoxime (HMLO). This patent describes how the absorption of HMLO can be significantly improved by including bile acids, such as desoxycholic acid or dehydrocholic acid, in the preparation. Another important patent involves hydroxamic acids and pharmaceutical preparations containing new compounds, specifically omega-(2'-naphthoxy)-alkylhydroxamic acids. These compounds exhibit antiasthmatic properties and other pharmacologically valuable characteristics, achieved through a specific reaction process.
Career Highlights
Throughout his career, Jurgen Slapke has worked with several prominent companies in the pharmaceutical industry. He has been associated with VEB Arzneimittelwerk Dresden and VEB Fahlberg-List Chemische und Pharmazeutische Fabriken. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Slapke has collaborated with notable colleagues in his field, including Tankred Schewe and Thomas Strumpf. These partnerships have likely facilitated the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Jurgen Slapke's contributions to pharmaceutical innovations highlight his commitment to improving drug formulations and patient care. His patents reflect a deep understanding of the complexities involved in drug absorption and efficacy. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile